Business, Policy & Funding
Breaking news on Diagnostics business, policy & funding.
Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent
The Abbott Park, Illinois-based firm's global COVID-19-related sales were $2.3 billion in the fourth quarter, including $2.1 billion from rapid testing.
Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation
The move comes as the UK's Competition and Markets Authority cracks down on PCR test providers for price gouging and other improper business practices.
AnPac Bio Warned by Nasdaq Over Listing Requirement
The company has until July 18 to meet Nasdaq compliance by getting its market value of publicly held shares to at least $15 million.
Novacyt Preliminary FY2021 Revenues Down 65 Percent Amid Supply Contract Dispute
The company also warned that revenues from its COVID-19 testing products could be as much as 50 percent lower in the coming year.
Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
The high-throughput test combines CRISPR technology with an automated liquid handling platform from Agilent.
Jan 20, 2022
Jan 18, 2022
Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark
Jan 18, 2022